The study evaluated the effect of intra-alveolar administration of a thermosetting gel containing doxycyclyne hylcate 3% on patient discomfort after third molar surgery. Eighty-five consecutive patients requiring surgical removal of a single maxillary or mandibular impacted third molar were randomly selected and divided into 2 groups. After the onset of local anaesthesia, the experimental groups received 2 different antibiotic protocols: rifampicin for the first group and a thermosetting gel containing doxycyclyne hylcate 3% for the second group. Standardized surgical protocols were followed. The patients' perception of the severity of symptoms (pain, swelling, reddening, bleeding and body temperature) was assessed with a follow-up questionnaire (PoSSe scale). On the second postoperative day, pain, reddening and bleeding showed a statistically significant reduction in Group 2 compared with Group 1. There was no difference between the two groups when postoperative swelling was evaluated on the second day. From the third day, conversely, swelling decreased faster in Group 2 than in Group 1. Our data demonstrate that the use of the thermosetting gel containing doxycyclyne hylcate 3%, given as an intra-alveolar injection at the end of surgery, is effective in the prevention of postoperative symptoms after third molar extraction.
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The surgical removal of impacted third molars involves trauma to soft and bony tissue and can result in considerable pain, swelling, reddening and bleeding. These postoperative sequela can cause stress to the patient and affect the patient's quality of life after surgery. These sequelae can happen also after surgical-orthodontic treatments (1-3). Prediction of impaction of third molars in patients could be of great help in the planning of orthodontic treatment, surgery, or prostheses (4-8).
The need for better discomfort control in patients who undergo third molar surgery is widely recognized, and several types of medications have been proposed (9) . In order to improve the postoperative course, the surgical procedure must be appropriate and as far as possible non-traumatic; it is also useful to prescribe a suitable medication protocol.
The aim ofthe antibiotic prophylaxis, is to protect the patient from the consequences of transient bacteremia and to avoid potential contamination of the wound following surgery, which may cause various complications.
Although preparation for surgery aims to create an aseptic operating field, there is always the risk of infections linked to commensal bacteria within the oral cavity. Numerous studies addressed the use and choice of antibiotics used for prophylaxis and therapy of bacterial infections of the oral cavity; guidelines have been proposed by various international organizations, although to date there is still no consensus.
In clinical practice the choice of antibiotic prophylaxis, in the absence of an antibiogram, is directed towards the administration of agents with a broad spectrum of action, active even against antibiotic-resistant strains (10) (11) (12) (13) .
Antibiotics can be administered systemically or topically. The oral administration route, which is the most common, has several side effects such as hypersensitivity reactions, development or presence of bacterial resistance, gastrointestinal intolerance. In addition, the active ingredient may interfere with the composition of the oral microfl.ora.
Topical administration of the antibiotic can reduce these risks and, at the same time, provide pharmacologically active concentrations in the areas where the therapeutic action is required. The therapeutic effect in such cases is assured due to the pharmaceutical formulations that give a prolonged and controlled release of active substances at the application site.
Prolonged drug release offers numerous benefits: high efficiency, control of the concentration of active ingredient at the application site, thus reducing adverse reactions (14-15). A thermosetting gel was used containing doxycyclyne hylcate 3%.
Our research assesses the clinical use ofa new filmforming antibiotic solution which could potentially be useful for the prophylaxis of postsurgical local complications; it was compared with a well known topical antibiotic, Rifampicin.
MATERIALS AND METHODS
Eighty-five consecutive patients of both sexes, aged between 16 and 35 years, requiring surgical removal of a single mandibular impacted third molar under local anesthesia were selected between February and July 2011 and were included in this randomised study. Informed written consent was obtained from all patients or patient's parent or guardian before they were included in this study.
The subjects were free of caries, extensive periodontal disease, pain, or other inflammatory symptoms at the time of operation. The patients were free from systemic diseases, had no history of psychiatric illness, and had no history of known allergies to the drugs used in this study. Exclusion criteria were: pregnant or lactating women; and use of any antibiotic or anti-inflammatory drug within 2 weeks of study commencement. Also excluded were cases in which surgery lasted more than 60 minutes, surgery affected by complications occurring during surgery making the procedures not comparable, and cases in which concomitant use of non-trial drugs were used during the observation period. At the initial examination the information was recorded by a single blinded clinical examiner to the administration of the test medication. In no case was the surgeon who had operated on the patients involved in the preoperative or postoperative assessment.
Medication
Subjects were randomly allocated to receive the test medication, doxycyclyne hylcate 3% (Thermosetting gel, Monteresearch, Bollate, Italy), or control medication (Rifampicin). All patients in this study routinely received a prophylactic preoperative dose of oral antibiotic 2 g, amoxicillinlclavulanic acid 1 hour before surgery (Augumentin;
GlaxoSmithKline, Verona, Italy). Postoperative antibiotic was prescribed for 5 days (2 capsules per day).
A mouth rinse with 15 mL of 0.2% chlorhexidine solution (Dentosan; Pfizer Consumer Healthcare, Rome, Italy) was used before surgery for I minute and for 10 days after surgery for 1 minute thrice daily. Oral Aulin, nimesulide 100 mg (Roche S.pA, Milano, Italy) was administered immediately after surgery and was prescribed to be taken every 8 hours (maximum 3 doses in all). The patients were advised to avoid any drugs apart from the ones prescribed and to not seek any medical help elsewhere for postoperative problems.
Surgery
To minimise differences due to operator variability, all of the surgical extractions were performed by the same oral surgeon. With the exception of the use of topical antibiotics, each patient had similar operative procedures, in the same operative room and under similar conditions, using 2% mepivacaine with epinephrine 1:100,000 as a local anaesthetic without a sedative premedication. At the report of the subjective signs of anaesthesia, dexamethasone 4 mg (Soldesam; Lab Farmacologico Milan Sri, Milan, Italy) was injected into the buccal 
Pain
The first day after surgery the pain In the two control group . There were no statistically significant differences between study groups with regard to patient characteristics or duration of surgery. At the follow-up, no patient had developed local infection or serious postoperative complications.
RESULTS
Data of 84 of the 85 patients were included in the analysis. One patient was dropped from the study because the surgery lasted more than 60 minutes. There were 41 patients in the test group, and 43 in the
Postoperative assessment
The patient was given the usual postoperative instructions and received a questionnaire, after being instructed on its use. The benchmarks in the evaluation of signs of inflammation were subjective and objective. The first criterion was analyzed by the change in the patient's pain symptoms on a scale with a score from 0 to 3 (0 = no pain, I = mild pain, 2 = moderate pain, 3 = severe pain). The evaluation of oedema was analyzed through changes in the patient's oedema symptoms on a scale with a score from 0 to 2 (0 = no oedema , I = mild swelling, 2 = significant swelling) . The evaluation of reddening and bleeding was analyzed by the change in the patient's symptoms on a scale from 0 to I (0 = absent, I = present). Patients recorded their assessment daily during the 10 days following surgery on a special card, on which they could also record the occurrence of any side effects. Patients were also instructed to measure and record the body temperature (DC) in order to monitor the occurance of any fever.
To evaluate the recorded parameters during the tenday duration test, two groups were created in order to highlight the presence (scores different from zero) or absence (scores equal to zero) ofsymptoms. The statistical analyses were performed with a computerized statistical program (SPSS version 11 .5 for Windows NT, SPSS Inc., Chicago, l1Iinois, USA). The statistical significance of results was assessed with the chi-square test. vestibule tissues.
Access to the third molar was achieved from the buccal aspect, and bone removal occurred with the use of a round bur in a straight handpiece under continuous irrigation with a sterile saline solution. If necessary, sectioning of crown and roots was performed with a fissure bur. After tooth extraction, the alveolus was inspected and curetted to remove granulation tissue.
The alveolus of the test group was injected with a needle bevel syringe with I mL doxycycline 3%, while the alveolus of the control group was irrigated with a vial of antibiotic rifampicin (Rifocin, Gruppo Lepetit SrI, Milan, Italy).
Primary closure was obtained using a 4-0 silk suture. An ice pack was then applied to the patient's face for 20 minutes .
o Rifamicin + Dexamethasone n = 43 o Doxycycline + Dexamethasone n =41 groups was almost the same, but from the second day pain in the Test group (doxycyclyne hylcate 3%) decreased faster than it did in the Control group (Rifampicin). Throughout the post-operative period, pain symptoms of the Test group were less severe than it was in the Control group (Fig. 1) .
Oedema
In both groups, facial swelling was most severe the day after surgery. The face began to return to its baseline contour by the sixth day post-operation. Table II shows the differences in oedema between the 2 groups observed over time (Fig. 2) . Post-operative oedema tended to decrease faster between the second and the sixth day postoperative in the test group, but no statistically significant differences were observed. 
Reddening
In the Test group reddening was less severe than in the control group, but from the seventh day after surgery there was no differences (Fig. 3) . 
Bleeding
The day after surgery bleeding was higher in the Test group, but from the second day after surgery it slowed down faster than it did in the Control group (Fig. 4) . From the fourth day there were no differences between the two groups.
Body temperature
Patients in the Test group appeared to have had a body temperature over 37°C for less days compared to the control group. No patient, however, subjectively described the increase of the body temperature recorded as a fever episode (Fig. 5 ).
DISCUSSION
The surgical removal of third molar is often associated with severe postoperative discomfort, even when teeth are removed using gentle surgical techniques (l, 6, 7). It is often thus attempted to reduce postsurgical sequelae by using antiinflammatory drugs. However, it is by no means certain that swelling and oedema can be reduced with corticosteroids. The use of dexamethasone, administered as an intraoral injection (4 mg) at the time of surgery, is effective in preventing postoperative oedema. Its action mechanism may be through inhibiting the conversion of phospholipids into arachidonic acid by phospholipase A 2 , thus halting the resultant synthesis of prostaglandins, leukotrienes, or thromboxane-related substances as 1. Grossi GB, Maiorana C. Garramone RA, Borgonovo REFERENCES doxycyclyne hylcate 3% had reduced post-operative symptoms. The thermosetting gel we used solidifies between 14 and 19°C. The temperature in the oral cavity is higher, meaning that the thermosetting gel remain in its solid form for a prolonged period. This characteristic allows constant topical release of the active principle at the surgical site. All the parameters were determined subjectively according to the patient's perception of the changes using a PoSSe subscale (21) .
The suitability of the use of the PoSSe scale to subjectively assessing postoperative parameters in third molar extraction has been proved by Grossi et al. (I). Analysis of the data obtained from this research and clinical statistics, showed doxycyclyne hylcate 3% to be more effective than Rifampicin; test group values were lower than those of the control group.
The results thus provide a basis for injecting doxycyclyne hylcate 3% thermosetting gel into the tooth alveolus after third molar surgery to reduce postoperative symptoms. It appears that such direct treatment at the surgical site achieves a constant and higher effective drug concentration, due to the solidity of the gel, enabling the active principle to stay on the site longer than just rinsing with rifampicin (22) .
In conclusion, the results of this study provides a basis for the submucosal administration of doxycycline 3% gel to achieve a reduction of postoperative symptoms that is comparable to, or greater than, the other protocol used here. Presumably, injection of doxycyclyne hylcate 3% in the surgical site using thermosetting gel as a carrier achieves a higher effective drug concentration at the site of injury without loss due to distribution to other compartments or the onset of elimination processes.
Moreover, when the third molar is removed surgically, this topical submucosal antibiotic is convenient for both surgeon and patient, as the effectiveness of oral administration reduces the patient's perception of symptoms, and enables the surgeon to provide a less stressful post-operative period for the patient. In this study both groups received 4 mg dexamethasone injected into the buccal vestibule tissues to reduce oedema. Moreover, patients in the test group, who received an intramucosal injection of thermosetting gel containing 3% doxycycline hyclate had lower values of all parameters studied than the control group.
Doxycycline, a broad-spectrum semisynthetic tetracycline, is one of the antibiotics most widely used in many fields of medicine; it is unanimously reported to be of great importance in the treatment of various diseases, especially periodontitis (16, 17) .
It is more active than the tetracycline against many bacterial species including the Streptococcus pyogenes, enterococci and various anaerobes and in the treatment of sensitive infections because of its fairly reliable absorption and its long half-life (18) .
In vitro testing has shown that Porophyromonas gingivalis, Prevotella intermedia, Campylobacter rectus, and Fusobacterium nucleatum, which are associated with periodontal disease, are susceptible to doxycycline at a concentration of <e.Oug/ml. (19, 20) .
In this single-centred, single-blinded, randomised, clinical trial we demonstrated that the patients treated with a thermosetting gel containing
